Annual report pursuant to Section 13 and 15(d)

Note 8 - Stockholders' Deficit (Tables)

v3.10.0.1
Note 8 - Stockholders' Deficit (Tables)
12 Months Ended
Jun. 30, 2018
Stockholders’ deficit:  
Schedule of Warrant Activity

Warrant detail for the year ended June 30, 2018 is reflected below:

 

   

Number

of

Warrants

 

Weighted Average

Exercise

Price Per Warrant 

  Remaining Contract Term (# years)
Warrants outstanding and exercisable at June 30, 2017     2,342,590     $ 1.97         0.12 - 1.55   
 Warrants issued
    —       $ —         —    
 Warrants exchanged
    (141,643 )   $ 0.60       —    
 Warrants expired
    (460,157 )   $ 2.15       —    
 Warrants outstanding and exercisable at June 30, 2018
    1,740,790     $ 2.03       0.74  

 

Warrant detail for the year ended June 30, 2017 is reflected below:

 

   

Number

of

Warrants

 

Weighted Average

Exercise

Price Per 

Warrant

  Remaining Contract Term (# years)
Warrants outstanding and exercisable at June 30, 2016     2,804,010     $ 2.00         0.39 - 2.50   
Warrants exchanged     (271,420 )   $ 1.40       —    
Warrants expired     (190,000 )   $ 3.00       —    
Warrants outstanding and exercisable at June 30, 2017     2,342,590     $ 1.97         0.12 - 1.55   

 

Schedule of Stock Option Activity

Activity in stock options during the year ended June 30, 2018 and related balances outstanding as of that date are reflected below:

 

   

Number of

Shares

   

Weighted

Average

Exercise Price

   

Weighted

Average

Remaining

Contract

Term (# years)

 
Outstanding at June 30, 2017     716,277     $ 1.10       7.09  
Granted     2,925,106       0.78          
Exercised     -                  
Forfeited and cancelled     (96,910 )   $ 0.57          
Outstanding at June 30, 2018     3,544,473     $ 0.83       8.87  
Exercisable at June 30, 2018     1,356,806     $ 0.74       7.71  

 

Activity in stock options during the year ended June 30, 2017 and related balances outstanding as of that date are reflected below:

 

   

Number of

Shares

   

Weighted

Average

Exercise Price

   

Weighted

Average

Remaining

Contract

Term (# years)

 
Outstanding at June 30, 2016     900,402     $ 1.13        
Granted     -                
Exercised     -                
Forfeited and cancelled     (184,125 )   $ 1.63        
Outstanding at June 30, 2017     716,277     $ 1.10       7.09  
Exercisable at June 30, 2017     589,476     $ 1.11       6.80  

 

Schedule of Stock-based Compensation
Years ended June 30,   2018     2017  
Research and development   $ 96,000     $ 13,000  
General and administrative     159,000       27,000  
Total stock-based compensation expense   $ 255,000     $ 40,000  
Schedule of Stock Options Valuation Assumptions
    2018     2017  
Expected volatility 138% -143%         100%  
Risk free interest rate   1.76% - 2.63% 1.31%  
Forfeiture rate 20% -2 3%     17%-24%  
Dividend yield   0%             0%  
Expected term (years) 5         3